New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 15, 2013
14:43 EDTGMEDGlobus Medical reported solid preliminary Q4 results, says Piper Jaffray
After Globus reported higher than expected preliminary Q4 revenue, Piper Jaffray continues to view the spine market as stable, if not modestly improving. The firm continues to recommend buying the stock.
News For GMED From The Last 14 Days
Check below for free stories on GMED the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 11, 2014
07:19 EDTGMEDGlobus Medical reiterated as top pick at Piper Jaffray
Piper Jaffray reiterates Globus Medical as a top pick and raised its price target for shares to $28 from $26. Piper views the stock's valuation as among the most compelling in its coverage universe. It believes Globus' underlying business is solid and reiterates an Overweight rating on the stock. JMP Securities this morning initiated Globus Medical with an Outperform rating and $25 price target.
06:24 EDTGMEDGlobus Medical initiated with an Outperform at JMP Securities
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use